Cooper Companies (COO) Stock Price, News & Analysis

Company Overview

Cooper Companies, Inc. is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas. CooperVision sells its products through eye-care professionals and distributors in markets around the world.

CooperSurgical provides medical devices, instruments and diagnostic products for women’s health and fertility care. Its offerings support areas such as in vitro fertilization, reproductive health, contraception, gynecological procedures and in-office surgical care. The company serves healthcare providers, hospitals, fertility clinics and laboratories internationally.

Key Stats

• Today's Range: $55.84 to $56.74
• 50-Day Range: $53.27 to $76.82
• 52-Week Range: $51.01 to $89.83
• Volume: 5.40 million shs
• Average Volume: 2.65 million shs
• Market Capitalization: $10.77 billion
• P/E Ratio: 19.33
• Dividend Yield: N/A
• Price Target: $71.47
• Consensus Rating: Hold

Cooper Companies Stock Analysis - MarketRank™

Cooper Companies scored higher than 87% of companies evaluated by MarketBeat, and ranked 52nd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Cooper Companies has received a consensus rating of Hold. The company's average rating score is 2.16, and is based on no strong buy ratings, 5 buy ratings, 12 hold ratings, and 2 sell ratings.

Upside Potential

Cooper Companies has a consensus price target of $71.47, representing about 26.2% upside from its current price of $56.63.

Amount of Analyst Coverage

Cooper Companies has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.19%

Earnings Growth

Earnings for Cooper Companies are expected to grow by 4.19% in the coming year, from $4.53 to $4.72 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cooper Companies is 19.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.75.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cooper Companies is 19.33, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.98.

Price to Earnings Growth Ratio

Cooper Companies has a PEG Ratio of 2.25. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Cooper Companies has a P/B Ratio of 1.37. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.38% of the float of Cooper Companies has been sold short.

Short Interest Ratio / Days to Cover

Cooper Companies has a short interest ratio ("days to cover") of 1.89, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cooper Companies has recently increased by 13.98%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cooper Companies does not currently pay a dividend.

Dividend Growth

Cooper Companies does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.53

News Sentiment

Cooper Companies has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for Cooper Companies this week, compared to 9 articles on an average week.

Search Interest

19 people have searched for COO on MarketBeat in the last 30 days. This is an increase of 171% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Cooper Companies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.9 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

3 insiders have purchased shares of Cooper Companies in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $1,880,039.00 in company stock, which represents 0.0175% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Cooper Companies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,880,039.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

2.08% of the stock of Cooper Companies is held by insiders.

Percentage Held by Institutions

24.39% of the stock of Cooper Companies is held by institutions.

Company Calendar

• Last Earnings: 9/09/2026
• Today: 9/29/2026
• Fiscal Year End: 10/31/2026
• Next Earnings (Estimated): 12/03/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:COO
• Previous Symbol: NYSE:COO
• CIK: 711404
• Web: www.coopercos.com
• Phone: (925) 460-3600
• Fax: 925-460-3649
• Employees: 15,000
• Year Founded: 1958

Price Target and Rating

• Average Price Target for Cooper Companies: $71.47
• High Price Target: $103.00
• Low Price Target: $58.00
• Potential Upside/Downside: +26.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.16
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.93
• Trailing P/E Ratio: 19.33
• Forward P/E Ratio: 12.50
• P/E Growth: 2.25
• Net Income: $374.90 million
• Net Margins: 13.46%
• Pretax Margin: 10.91%
• Return on Equity: 10.90%
• Return on Assets: 7.24%

Debt

• Debt-to-Equity Ratio: 0.23
• Current Ratio: 1.22
• Quick Ratio: 0.73

Sales & Book Value

• Annual Sales: $4.09 billion
• Price / Sales: 2.63
• Cash Flow: $6.19 per share
• Price / Cash Flow: 9.15
• Book Value: $41.44 per share
• Price / Book: 1.37

Miscellaneous

• Outstanding Shares: 190,150,000
• Free Float: 186,200,000
• Market Cap: $10.77 billion
• Optionable: Optionable
• Beta: 0.82